|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/28 | (2015.01) |
| A61K 31/557 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 9/00 | (2006.01) |
| (11) | Number of the document | 3415150 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18185761.6 |
| Date of filing the European patent application | 2014-01-08 | |
| (97) | Date of publication of the European application | 2018-12-19 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361750458 P | 2013-01-09 | US |
| (72) |
Jeffs, Roger , US
Petersen, Thomas , US
Ilagan, Roger M. , US
Wade, Michael , US
|
| (73) |
United Therapeutics Corporation ,
1040 Spring Street, Silver Spring, MD 20910,
US
|
| (54) | TREATMENT OF VASCULOPATHY WITH PROSTACYCLIN AND MESENCHYMAL STEM CELLS |
| TREATMENT OF VASCULOPATHY WITH PROSTACYCLIN AND MESENCHYMAL STEM CELLS |